HeartBeam Partners With HeartNexus to Expand Remote Cardiac Monitoring Services

HeartBeam has announced a strategic partnership with HeartNexus Inc. to deliver comprehensive remote cardiology services, marking a significant advancement in accessible cardiac care. The collaboration enables HeartBeam to offer 24/7 cardiology reader services for patients experiencing cardiac symptoms outside traditional healthcare settings, addressing a critical gap in continuous cardiac monitoring.

The partnership leverages HeartBeam's patented 3D technology, which allows patients to capture 30-second, cable-free ECG recordings whenever symptoms occur. These recordings are transmitted directly to HeartNexus cardiologists for immediate interpretation, providing real-time cardiac assessment without requiring hospital visits. Robert Eno, CEO of HeartBeam, emphasized that working with HeartNexus accelerates the company's mission to make medical-grade cardiac monitoring accessible beyond medical facility walls.

This collaboration represents a substantial expansion of HeartBeam's ecosystem, incorporating real-time cardiology feedback and laying groundwork for future integration of AI wellness and wearable features. The partnership comes shortly after HeartBeam's 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, while the company's 12-Lead ECG synthesis software remains under FDA review. Additional information about the company's technology and developments is available at https://ibn.fm/BEAT.

The implications of this partnership extend beyond immediate patient care, potentially reshaping how cardiac conditions are detected and managed globally. By enabling continuous cardiac monitoring outside clinical settings, the technology could significantly reduce emergency room visits and hospital admissions for cardiac events. The 24/7 availability of cardiology interpretation services addresses the unpredictable nature of cardiac symptoms, which often occur outside regular business hours when traditional medical facilities may be inaccessible.

HeartBeam's platform technology represents the first cable-free device capable of collecting ECG signals in three non-coplanar directions and synthesizing them into a 12-lead ECG. This innovation, supported by over 20 issued patents, allows physicians to identify cardiac health trends and acute conditions while directing patients to appropriate care entirely outside medical facilities. The full details of the partnership announcement can be found at https://ibn.fm/HqwuQ.

For the broader healthcare industry, this partnership signals a shift toward decentralized cardiac care models that could reduce healthcare costs while improving patient outcomes. The integration of real-time interpretation services with portable ECG technology creates a comprehensive remote monitoring solution that could benefit patients in rural areas, those with mobility limitations, and individuals requiring continuous cardiac surveillance. The forward-looking nature of this development is subject to various factors beyond management's control, as detailed in the company's SEC filings available at http://IBN.fm/Disclaimer.